BioCentury
ARTICLE | Financial News

Aeglea completes venture financing

March 30, 2015 7:00 AM UTC

Aeglea Biotherapeutics Inc., Austin, Texas Business: Cancer, Endocrine/Metabolic Date completed: 2015-03-23 Type: Venture financing Raised: $44 million Investors: Lilly Ventures; Novartis Venture Fund...